X-38299102-G-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS1

This summary comes from the ClinGen Evidence Repository: NM_001034853.2(RPGR):c.1099C>G (p.Pro367Ala) is a missense variant predicted to cause the substitution of proline by alanine at amino acid 367. This variant is present in gnomAD v.4.1.0 at a frequency of 0.00004278 among hemizygous individuals, with 17 variant alleles / 397,359 total alleles, which is higher than the ClinGen X-linked IRD VCEP BS1 threshold of >0.000005 (BS1). The computational predictor REVEL gives a score of 0.285, which is below the ClinGen X-linked IRD VCEP threshold of < 0.290 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.02, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4). In summary, this variant is classified as likely benign for RPGR-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen X-linked IRD VCEP: BS1, BP4. (VCEP specifications version 1.0.0; date of approval 05/16/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10385542/MONDO:0100437/106

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000036 ( 0 hom. 15 hem. )

Consequence

RPGR
NM_001034853.2 missense

Scores

4
4
9

Clinical Significance

Likely benign reviewed by expert panel U:2B:3

Conservation

PhyloP100: 6.72

Publications

2 publications found
Variant links:
Genes affected
RPGR (HGNC:10295): (retinitis pigmentosa GTPase regulator) This gene encodes a protein with a series of six RCC1-like domains (RLDs), characteristic of the highly conserved guanine nucleotide exchange factors. The encoded protein is found in the Golgi body and interacts with RPGRIP1. This protein localizes to the outer segment of rod photoreceptors and is essential for their viability. Mutations in this gene have been associated with X-linked retinitis pigmentosa (XLRP). Multiple alternatively spliced transcript variants that encode different isoforms of this gene have been reported, but the full-length natures of only some have been determined. [provided by RefSeq, Dec 2008]
RPGR Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 3
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • RPGR-related retinopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • primary ciliary dyskinesia-retinitis pigmentosa syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • macular degeneration, X-linked atrophic
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPGRNM_001034853.2 linkc.1099C>G p.Pro367Ala missense_variant Exon 10 of 15 ENST00000645032.1 NP_001030025.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPGRENST00000645032.1 linkc.1099C>G p.Pro367Ala missense_variant Exon 10 of 15 NM_001034853.2 ENSP00000495537.1
ENSG00000250349ENST00000465127.1 linkc.172-367019G>C intron_variant Intron 3 of 8 5 ENSP00000417050.1

Frequencies

GnomAD3 genomes
AF:
0.0000268
AC:
3
AN:
111979
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000563
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000769
AC:
14
AN:
182000
AF XY:
0.0000901
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000173
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000364
AC:
40
AN:
1097816
Hom.:
0
Cov.:
31
AF XY:
0.0000413
AC XY:
15
AN XY:
363214
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26398
American (AMR)
AF:
0.00
AC:
0
AN:
35195
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19375
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54068
European-Finnish (FIN)
AF:
0.0000494
AC:
2
AN:
40492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.0000404
AC:
34
AN:
841908
Other (OTH)
AF:
0.0000868
AC:
4
AN:
46076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000268
AC:
3
AN:
111979
Hom.:
0
Cov.:
23
AF XY:
0.0000586
AC XY:
2
AN XY:
34145
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30827
American (AMR)
AF:
0.00
AC:
0
AN:
10491
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3603
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2708
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6037
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000563
AC:
3
AN:
53244
Other (OTH)
AF:
0.00
AC:
0
AN:
1494
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.000124
AC:
15

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:2Benign:3
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:1Benign:1
Mar 30, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.P367A variant (also known as c.1099C>G), located in coding exon 10 of the RPGR gene, results from a C to G substitution at nucleotide position 1099. The proline at codon 367 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Uncertain:1
Jan 01, 2021
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
Apr 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RPGR: BP4, BS1 -

RPGR-related retinopathy Benign:1
May 20, 2025
ClinGen X-linked Inherited Retinal Disease Variant Curation Expert Panel, ClinGen
Significance:Likely benign
Review Status:reviewed by expert panel
Collection Method:curation

NM_001034853.2(RPGR):c.1099C>G (p.Pro367Ala) is a missense variant predicted to cause the substitution of proline by alanine at amino acid 367. This variant is present in gnomAD v.4.1.0 at a frequency of 0.00004278 among hemizygous individuals, with 17 variant alleles / 397,359 total alleles, which is higher than the ClinGen X-linked IRD VCEP BS1 threshold of >0.000005 (BS1). The computational predictor REVEL gives a score of 0.285, which is below the ClinGen X-linked IRD VCEP threshold of < 0.290 and predicts a non-damaging effect on RPGR function. Additionally, the splicing impact predictor SpliceAI gives a delta score of 0.02, which is below the ClinGen X-linked IRD VCEP recommended threshold of <0.1 and does not strongly predict an impact on splicing (BP4). In summary, this variant is classified as likely benign for RPGR-related retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen X-linked IRD VCEP: BS1, BP4. (VCEP specifications version 1.0.0; date of approval 05/16/2025). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.36
.;.;T;.;.;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.57
.;T;T;.;T;T
M_CAP
Pathogenic
0.41
D
MetaRNN
Uncertain
0.51
D;D;D;D;D;D
MetaSVM
Benign
-0.52
T
MutationAssessor
Uncertain
2.4
M;M;M;M;M;.
PhyloP100
6.7
PrimateAI
Benign
0.40
T
PROVEAN
Pathogenic
-6.9
D;.;D;.;D;.
REVEL
Benign
0.28
Sift
Uncertain
0.0030
D;.;D;.;.;.
Sift4G
Pathogenic
0.0
D;.;D;.;D;.
Polyphen
0.84
P;P;.;.;.;.
Vest4
0.62
MutPred
0.48
Gain of catalytic residue at P367 (P = 0.0137);Gain of catalytic residue at P367 (P = 0.0137);Gain of catalytic residue at P367 (P = 0.0137);Gain of catalytic residue at P367 (P = 0.0137);Gain of catalytic residue at P367 (P = 0.0137);.;
MVP
0.40
MPC
0.17
ClinPred
0.52
D
GERP RS
4.3
Varity_R
0.85
gMVP
0.80
Mutation Taster
=59/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs769641256; hg19: chrX-38158355; API